Business Wire

ANAM Electronics Launches OTT-Equipped Dolby Atmos Soundbar

Share

ANAM Electronics Co., Ltd. (CEO: Kim Tae-Soo) (KRX: 008700), a global A/V equipment specialist, and Technicolor Connected Home (Euronext Paris: TCH; OTCQX: TCLRY), a leading customer-premises equipment distributor, launched the world’s first Dolby Atmos OTT integrated soundbar with built-in 4K streaming.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220323006057/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

ANAM Electronics, a global A/V equipment specialist, launched the world’s first Dolby Atmos OTT integrated soundbar with built-in 4K streaming. Viewers are immersed in a three-dimensional soundscape by the bar’s eight speakers and three amplifiers. (Graphic: Business Wire)

The new soundbar is the first-ever over-the-top media services (OTT) integrated soundbar for paid broadcasting through Android’s TV service, equipped with the world-class sound technology Dolby Atmos® and the industry’s top-tier imaging technology Dolby Vision™. Viewers are immersed in a three-dimensional soundscape by the bar’s eight speakers and three amplifiers. The convenience of Google voice recognition is built-in.

With a 50-year history as a technological powerhouse specializing in audio and sound systems, ANAM Electronics began producing soundbars in 2013. Recently, ANAM has expanded its business by providing soundbars of various types tailored to a wide range of customers, which has helped deliver more than 50% growth annually over the last three years.

“With online, OTT services such as Netflix and Disney+ and devices increasing, we anticipate that the innovative convenience of this product, which offers excellent sound quality and an outstanding user experience, will become a benchmark for the industry,” said ANAM Electronics CEO Kim Tae-Soo.

According to Mercedes Pastor, senior vice president for Eurasia at Technicolor Connected Home, consumers have demonstrated rising interest in convenient and cost-effective theatrical-quality entertainment experiences in their homes.

“Technicolor Connected Home is working closely with ANAM Electronics to provide integrated, immersive audio and visual experiences that consumers can enjoy right out of the box. The 150-watt multi-speaker soundbar delivers high-fidelity surround sound while offering rich HDR picture quality that is easy to deploy and install,” she said.

About ANAM Electronics

Founded in 1973, ANAM Electronics Co., Ltd. is a leading original design manufacturer (ODM) of audio products, including AV receivers, AI soundbars, and wireless speakers. More detailed information is available on http://www.aname.co.kr/eng/.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

ANAM Electronics
Brian Oh
+82-2-6424-4762
Infodesk@aname.co.kr

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Biocytogen and Acepodia Expand Collaboration Through Option-based Evaluation Framework for First-in-Class Bispecific and Dual-Payload ADCs (BsAD2C)9.1.2026 14:00:00 EET | Press release

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315) and Acepodia (6976:TT), today announced that the companies have entered into an option and license agreement designed to enable the structured evaluation of bispecific antibody-drug conjugate (BsADC) programs to further advance the development of dual-payload bispecific antibody-drug conjugates (BsAD2Cs). The agreement grants Acepodia an option to obtain an exclusive worldwide license from Biocytogen for two BsADC programs. Under the terms of the agreement, Biocytogen is eligible to receive an upfront option fee and, upon Acepodia’s exercise of the option, additional payments including option exercise fees, development, regulatory, and commercial milestone payments, as well as royalties on future product sales. The financial terms of the agreement were not disclosed. “This new agreement builds upon our recent co-development collaboration with Acepodia, which has focused on the evaluation and selection

Blockstream Capital Partners Announces Strategic Acquisition of Derivatives Trading Team from Numeus Group, Leveraging Strategic Partnership with Komainu9.1.2026 12:08:00 EET | Press release

Blockstream Capital Partners (“BCP”) today announced that it has entered into a strategic agreement to acquire a division within Numeus Group’s digital asset trading and investment business. The transaction includes the absorption of select Bitcoin focused trading strategies with a focus on yield generation as well as a ten person derivatives trading team led by Chief Investment Officer Deepak Gulati, a specialist in volatility and derivatives markets. Deepak Gulati, appointed Co-Chief Investment Officer of Blockstream Capital Management alongside Rodrigo Rodriguez, previously served as Global Head of Proprietary Trading at JPMorgan, before founding Argentiere Capital, a multibillion-dollar volatility-focused hedge fund. With a thesis that derivatives would drive Bitcoin and digital asset market maturity, he co-founded Numeus Group in 2021 to develop institutional-grade trading, risk management and market-structure capabilities. Komainu, an existing BCP strategic investment, has played

Autel Unveils Strategic Shift at CES 2026: Building the AI-Powered Infrastructure of Future Cities9.1.2026 11:44:00 EET | Press release

At the Consumer Electronics Show (CES), Autel Energy is presenting its latest AI-driven smart hardware and software systems for the future of intelligent urban operations. This year’s showcase highlights Autel’s shift from AI concept validation to scenario-based engineering deployment, emphasizing closed-loop execution across real-world infrastructure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260101511436/en/ Autel Energy New Product Debut at CES 2026 Focusing on two key domains — Smart Energy and Smart Inspection — the company is unveiling a range of new products. In Smart Energy, Autel is introducing V2G (Vehicle-to-Grid) AC charger for homes and DC charging solution for fleets, strengthening its multi-tier energy touchpoint strategy from households to commercial operations. Live demonstrations at the booth will feature a smart charging robot showcasing automated plug-in capabilities. In Smart Inspection, Autel will

Allianz and Anthropic Forge Global Partnership to Advance Responsible AI in Insurance9.1.2026 11:00:00 EET | Press release

Allianz SE and Anthropic today announced a global partnership to accelerate the adoption of responsible Artificial Intelligence (AI) at Allianz. The collaboration centers on three transformative projects within Allianz Group designed to empower Allianz employees and accelerate operations, while setting new benchmarks for accuracy. “With this partnership, Allianz is taking a decisive step to address critical AI challenges in insurance. Anthropic’s focus on safety and transparency complements our strong dedication to customer excellence and stakeholder trust. Together, we are building solutions that prioritize what matters most to our customers while setting new standards for innovation and resilience,” said Oliver Bäte, CEO of Allianz SE. “Insurance is an industry where the stakes of using AI are particularly high: the decisions can affect millions of people. Allianz and Anthropic both take that very seriously, and we look forward to working together to make insurance better for those w

MRM Health Secures FDA IND Clearance to Launch its Phase 2b Trial of MH002 in Mild-to-Moderate Ulcerative Colitis9.1.2026 08:00:00 EET | Press release

MRM Health NV, a clinical-stage biopharmaceutical company pioneering microbiome-based therapeutics for inflammatory diseases and immune-oncology, today announced that the U.S. Food and Drug Administration (FDA) has granted clearance of its Investigational New Drug (IND) application for its lead program MH002. This enables the initiation of the STARFISH-UC Phase 2b clinical trial in patients with mild-to-moderate ulcerative colitis, marking a significant step forward in the development of next-generation therapies for inflammatory bowel diseases (IBD). About the STARFISH-UC Phase 2b Trial The STARFISH-UC trial is a randomized, double-blind, placebo-controlled study designed to confirm the promising efficacy signals and favorable safety profile previously observed in MH002’s Phase 2a studies. MH002, a rationally designed live microbial consortium, is the most advanced Live Biotherapeutic Product (LBP) of its kind, targeting disease-specific mechanisms through a synergistic combination of

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye